HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of localized intravascular coagulopathy with venous malformations.

AbstractOBJECTIVE:
To determine which venous malformations (VMs) are at risk for coagulopathy. Venous malformations are slow-flow vascular malformations present at birth, and localized intravascular coagulopathy (LIC) causes pain and thrombosis within a lesion and severe bleeding during surgical procedures.
DESIGN:
Prospective convenience sample accrued from 2 multidisciplinary sites in Brussels, Belgium, and Caen, France.
PARTICIPANTS:
The study population comprised 140 patients with clinical data and coagulation parameters. Magnetic resonance imaging was performed for 110 patients.
MAIN OUTCOME MEASURE:
Measurement of D-dimer levels.
RESULTS:
Of the 140 participants, 59 (42%) showed high D-dimer levels, 36 (61%) of whom had levels higher than 1.0 microg/mL. Six of the participants had low fibrinogen levels. In univariate analysis, large surface, presence of palpable phleboliths, and truncal localization were associated with high D-dimer levels. In the multivariate analysis, only large surface area and presence of phleboliths remained independently associated with high D-dimer levels. Severe LIC, characterized by concomitant low fibrinogen level, was associated with extensive venous malformations of the extremities.
CONCLUSIONS:
Localized intravascular coagulopathy is statistically significantly associated with large and/or deep venous malformations that affect any location, which can have a palpable phlebolith. These patients are at risk of local pain due to thrombosis. Lesions with elevated D-dimer levels associated with low fibrinogen levels (severe LIC) commonly affect an extremity and have a high risk of hemorrhage. Low-molecular-weight heparin can be used both to treat the pain caused by LIC and to prevent decompensation of severe LIC to disseminated intravascular coagulopathy.
AuthorsAnne Dompmartin, Aurélie Acher, Pascal Thibon, Sébastien Tourbach, Cédric Hermans, Véronique Deneys, Ben Pocock, Agnès Lequerrec, Daniel Labbé, Marie-Thérèse Barrellier, Romain Vanwijck, Miikka Vikkula, Laurence M Boon
JournalArchives of dermatology (Arch Dermatol) Vol. 144 Issue 7 Pg. 873-7 (Jul 2008) ISSN: 1538-3652 [Electronic] United States
PMID18645138 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
Topics
  • Adolescent
  • Adult
  • Aged
  • Belgium (epidemiology)
  • Blood Coagulation Disorders (blood, complications, epidemiology, pathology)
  • Child
  • Child, Preschool
  • Female
  • Fibrin Fibrinogen Degradation Products (metabolism)
  • France (epidemiology)
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Pain Measurement
  • Prospective Studies
  • Risk Factors
  • Severity of Illness Index
  • Sex Factors
  • Ultrasonography
  • Vascular Malformations (blood, complications, diagnostic imaging, epidemiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: